BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 15693745)

  • 21. Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up.
    Altshuler L; Suppes T; Black D; Nolen WA; Keck PE; Frye MA; McElroy S; Kupka R; Grunze H; Walden J; Leverich G; Denicoff K; Luckenbaugh D; Post R
    Am J Psychiatry; 2003 Jul; 160(7):1252-62. PubMed ID: 12832239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and tolerability of treatments for bipolar depression.
    Vázquez GH; Holtzman JN; Tondo L; Baldessarini RJ
    J Affect Disord; 2015 Sep; 183():258-62. PubMed ID: 26042634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacotherapy of bipolar depression: an update.
    Thase ME
    Curr Psychiatry Rep; 2006 Dec; 8(6):478-88. PubMed ID: 17094928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of atypical antipsychotics in refractory depression and anxiety.
    Nemeroff CB
    J Clin Psychiatry; 2005; 66 Suppl 8():13-21. PubMed ID: 16336032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bipolar depression: diagnostic and treatment considerations.
    Thase ME
    Dev Psychopathol; 2006; 18(4):1213-30. PubMed ID: 17064435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bipolar depression: an overview.
    Oral ET; Vahip S
    IDrugs; 2004 Sep; 7(9):846-50. PubMed ID: 15470602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current landscape, unmet needs, and future directions for treatment of bipolar depression.
    Frye MA; Prieto ML; Bobo WV; Kung S; Veldic M; Alarcon RD; Moore KM; Choi DS; Biernacka JM; Tye SJ
    J Affect Disord; 2014 Dec; 169 Suppl 1():S17-23. PubMed ID: 25533910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Bipolar disorders--how to recognize and treat them].
    Grunze H; Sasse J; Forsthoff A; Bauer M
    MMW Fortschr Med; 2004 May; 146 Spec No 2():4-6, 8. PubMed ID: 15376694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lithium combinations in acute and maintenance treatment of unipolar and bipolar depression.
    Fawcett JA
    J Clin Psychiatry; 2003; 64 Suppl 5():32-7. PubMed ID: 12720482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New approaches in managing bipolar depression.
    Keck PE; McElroy SL
    J Clin Psychiatry; 2003; 64 Suppl 1():13-8. PubMed ID: 12625800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rationale for using lithium in combination with other mood stabilizers in the management of bipolar disorder.
    Goodwin FK
    J Clin Psychiatry; 2003; 64 Suppl 5():18-24. PubMed ID: 12720480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spotlight on olanzapine/fluoxetine in acute bipolar depression.
    Deeks ED; Keating GM
    CNS Drugs; 2008; 22(9):793-5. PubMed ID: 18698877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis and management of patients with bipolar II disorder.
    Yatham LN
    J Clin Psychiatry; 2005; 66 Suppl 1():13-7. PubMed ID: 15693747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bipolar depression: issues in diagnosis and treatment.
    Thase ME
    Harv Rev Psychiatry; 2005; 13(5):257-71. PubMed ID: 16251165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Challenges in the management of bipolar depression.
    Suppes T; Kelly DI; Perla JM
    J Clin Psychiatry; 2005; 66 Suppl 5():11-6. PubMed ID: 16038597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of bipolar disorder: a systematic review of available data and clinical perspectives.
    Fountoulakis KN; Vieta E
    Int J Neuropsychopharmacol; 2008 Nov; 11(7):999-1029. PubMed ID: 18752718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bipolar depression: a new role for atypical antipsychotics?
    Keck PE
    Bipolar Disord; 2005; 7 Suppl 4():34-40. PubMed ID: 15948765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Olanzapine-fluoxetine combination for the treatment of bipolar depression.
    Citrome L
    Expert Opin Pharmacother; 2011 Dec; 12(17):2751-8. PubMed ID: 22035291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does recent mania affect response to antidepressants in bipolar disorder? A re-analysis of STEP-BD data.
    Mousavi Z; Johnson S; Li D
    J Affect Disord; 2018 Aug; 236():136-139. PubMed ID: 29734096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.